Literature DB >> 6751839

Inspiratory resistance training in severe chronic obstructive pulmonary disease.

K Bjerre-Jepsen, N H Secher, A Kok-Jensen.   

Abstract

Twenty-eight patients with stable chronic obstructive pulmonary disease (COPD) undertook a training program with a simple respiratory apparatus for 15 min three times daily for 6 weeks. Fourteen patients were allocated to an inspiratory resistance training program and 14 to a control group. In all subjects the median FEV1 was 0.72 and the median FEV1/FVC was 39%. There was no difference in FEV1 or FEV1/FVC between the control and the test groups. In both groups of patients FEV1 FVC and the corresponding values during inspiration, FIV1 and FIVC, as well as MVV, were found unchanged following the training period. Inspiratory resistance tolerance increased in both groups but no significant difference in the improvement could be observed between the two groups. Both groups also showed a similar increase, 23 (76-10) %, in stair-climbing ability. There was no correlation between increases in inspiratory load tolerance and stair-climbing ability. It is suggested that both inspiratory load tolerance and work ability can be improved in COPD patients, but that inspiratory resistance training does not contribute to these improvements.

Entities:  

Mesh:

Year:  1981        PMID: 6751839

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  3 in total

Review 1.  The application of muscle endurance training techniques to the respiratory muscles in COPD.

Authors:  T K Aldrich
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  Controlled trial of respiratory muscle training in chronic airflow limitation.

Authors:  G Guyatt; J Keller; J Singer; S Halcrow; M Newhouse
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

3.  Desensitization to dyspnea in COPD with specificity for exercise training mode.

Authors:  Christopher B Cooper
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.